Axel Chemicals Recalls L-Citrulline Bulk Product Due to Contamination
Axel Chemicals is recalling 1,000 kg of L-Citrulline bulk product because an unknown compound was found in at least one drum.
The agency’s classification
FDA (Food): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class I recall, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death.
Plain-English summary
Axel Chemicals is recalling 1,000 kg of L-Citrulline bulk product, packaged in 25 kg units. The recall was initiated after an adverse event report from a consignee and the discovery of a compound other than L-Citrulline in at least one drum.
The affected product is identified by lot number 121109. The product was distributed in New York, New Jersey, and North Carolina.
Consumers and businesses with this product should stop using it and contact the recalling firm for instructions on return or disposal.
The recalled product
- Product
- L-Citrulline, bulk product, 25 kg
- Manufacturer
- Axel Chemicals
- Category
- Food — Food Ingredient
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot number 121109
Distribution
Related recalls
Same hazard · contamination
See all →- ModerateAVID Medical Recalls GYN Laparoscopy Packs Due to Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls GYN Laparoscopy Kits for Potential Lubricant Contamination
FDA (Devices) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- ModerateAvid Medical Recalls Robotic Prostatectomy Packs for Lubricant Contamination
FDA (Devices) · 2026-10-14
Similar recalls
- CriticalMedisca Recalls L-Citrulline API Due to Labeling Error
FDA (Drugs) · 2016-02-24
- ModerateVitacost L-Citrulline Amino Acid Supplement Recalled for Contamination
FDA (Food) · 2014-04-16
- SevereSertraline HCl Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Cyclosporine A Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Cisplatin Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereSildenafil Citrate Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-04-29